Leef Brands (LEEEF) Current Leases (2023 - 2026)

Leef Brands (LEEEF) posted Current Leases of $167154.0 for Q1 2026, up 4.29% sequentially from $160285.0 in Q4 2025.

Leef Brands (LEEEF) Current Leases (2023 - 2026) Analysis & Trends

Leef Brands has reported Current Leases for 4 years, with the latest figure at $167154.0 in Q1 2026.

Quarterly Current Leases changed N/A year-over-year to $167154.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $167154.0 (changed N/A YoY) and the FY2025 annual result came in at $160285.0, down 47.05% from the prior year.
Current Leases rose to $167154.0 in Q1 2026 per LEEEF's latest filing, from $160285.0 in the prior quarter.
Over five years, Current Leases peaked at $302736.0 in Q4 2024 and troughed at $160285.0 in Q4 2025.
A 4-year average of $209699.8 and a median of $187889.0 in 2023 frame the typical range for Current Leases.
The sharpest annual moves came in 2024 and 2025: Current Leases soared 45.11% in 2024, then tumbled 47.05% in 2025.
Over 4 years, Current Leases stood at $208624.0 in 2023, then surged by 45.11% to $302736.0 in 2024, then sank by 47.05% to $160285.0 in 2025, then increased by 4.29% to $167154.0 in 2026.
According to Business Quant data, Current Leases over the past three periods registered $167154.0, $160285.0, and $302736.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn	277,229.00

Download Data